Punitive damages in a catheter fracture case are available only when the patient can prove the manufacturer knew about the defect and chose to hide it. The fracture itself — even a serious one that sends plastic fragments into the bloodstream — supports compensatory damages for medical bills, pain and lost income, but it does not by itself support punishment.
That distinction is not theoretical. In September 2026, a bellwether jury awarded roughly $40 million in compensatory damages against Bard in a PowerPort catheter-fracture case on design-defect and failure-to-warn theories, yet awarded nothing in punitive damages after rejecting the fraudulent-concealment count, as Drugwatch reported on the verdict. Same injury, same defendant, two very different findings.
Table of Contents
- What catheter fracture is, and why regulators treat it as severe
- The legal standard punitive damages actually require
- Negligence is not enough — concealment is the hinge
- Preemption can close the door before damages are argued
- What limits the size of an award
- Practical steps for an affected patient
- Frequently Asked Questions
What catheter fracture is, and why regulators treat it as severe
A catheter is a thin tube placed into a vein or artery to deliver drugs, draw blood or reach a treatment site. "Fracture" means the tube breaks or separates while it is inside the body. The broken piece does not stay where it was: it travels with the blood. The FDA has been explicit about the stakes.
It designated BD/Bard's removal of PowerPICC intravascular catheters a Class I recall — its most serious category — because a resin material problem could cause the catheters to lose structural integrity and leak, exposing patients to embolism and infection, and it told clinicians and patients to watch for signs consistent with catheter fracture, in a communication updated January 5, 2026. Other manufacturers have faced the same failure mode. Teleflex and Arrow International recalled the ARROW Endurance Extended Dwell Peripheral Catheter System after 83 complaints and 18 injuries, with the FDA warning that fragments from a separated catheter may be left in the bloodstream and migrate elsewhere in the body; the firm's urgent recall letter was dated May 19, 2023. Medos International Sàrl, a Johnson & Johnson subsidiary, recalled 1,343 Cerebase DA Guide Sheath neurovascular catheters for fracture of the distal catheter shaft, which can cause procedural delay, vascular injury, hemorrhage and, rarely, embolism; three patients were injured and no root cause had been identified.
The legal standard punitive damages actually require
Compensatory damages restore what the patient lost. Punitive damages punish the defendant and deter others, and the bar is deliberately much higher. California's rule is representative. Under Civil Code § 3294, a plaintiff must prove by clear and convincing evidence — not the ordinary "more likely than not" standard — that the defendant acted with oppression, fraud or malice.
"Oppression" there means despicable conduct that inflicts cruel and unjust hardship in conscious disregard of a person's rights. The corporate limitation matters even more in device cases. Against a corporation, § 3294 allows punitive damages only if an officer, director or managing agent knew of the wrongdoing. A complaint file sitting in a mid-level engineering group is not automatically enough; the evidence has to reach decision-makers.
Negligence is not enough — concealment is the hinge
A manufacturer can design a catheter badly, fail to warn doctors adequately, and still face no punitive exposure. That is a negligence story. Punitive damages need a decision story: the company knew the device was failing and chose silence.
The contrast within Bard's own litigation history makes the line visible. In the Bard G2 IVC filter bellwether, a federal jury awarded $1.6 million in compensatory damages plus $2 million in punitive damages on negligent failure to warn, and the trial judge upheld the punitive award and denied a new trial, reasoning that the evidence showed Bard chose not to warn physicians of risks it already knew about. Put the two verdicts side by side and the pattern is clear: The injuries in both were real and documented. What separated them was the proof about what the company knew and when.
- **PowerPort 2026 bellwether** — ~$40 million compensatory, $0 punitive. Design defect and failure to warn proved; fraudulent concealment rejected.
- **G2 filter bellwether** — $1.6 million compensatory, $2 million punitive. Internal knowledge of an unwarned risk proved.
Preemption can close the door before damages are argued
Before a court reaches malice, it asks whether the claim can be brought at all. That turns on how the FDA cleared the device. In Riegel v. Medtronic (2008), the Supreme Court held that the Medical Device Amendments bar common-law claims attacking the safety or effectiveness of a Class III device that received FDA premarket approval — the device in that case was a Medtronic Evergreen balloon catheter.
Medtronic v. Lohr leaves claims about 510(k)-cleared devices unpreempted, because 510(k) clearance rests on a finding of substantial equivalence to an existing product, not an independent safety finding. For a patient, this is the first practical question a lawyer will ask about the specific catheter model. Most intravascular catheters reach the market through 510(k), which is why the PowerPort and filter cases proceeded to juries at all. A premarket-approved device points the other way.
What limits the size of an award
Even a punitive award that survives trial faces constitutional review. In BMW of North America v. Gore (1996), the Court set three guideposts: the reprehensibility of the conduct — treated as the most important — the ratio of punitive damages to actual or potential harm, and comparison with civil or criminal penalties authorized for comparable conduct. State Farm v. Campbell tightened the ratio analysis.
The Court struck down a $145 million punitive award and, while declining a bright-line rule, held that few awards exceeding a single-digit ratio to compensatory damages will satisfy due process, and that where compensatory damages are substantial a ratio near 1:1 may be the outer limit, in its 2003 opinion at 538 U.S. 408. Utah later remitted that award to $9 million. The arithmetic cuts against expectations in large catheter cases. A $40 million compensatory verdict is "substantial" by any reading, so the ratio ceiling pulls toward the low single digits — or toward one — rather than multiplying the figure.
Practical steps for an affected patient
The evidence that drives a concealment claim is mostly the manufacturer's, obtained in discovery. What a patient controls is the record that makes their own case provable.
One further caution: a recall announced after an implant does not establish prior knowledge. The Medos Cerebase recall closed with no root cause identified, which is a factual posture that supports a defect claim and undercuts a concealment claim at the same time.
- Get the device identification: brand, model, lot number and the implant date, which appear in the operative note or the implant card.
- Ask the hospital in writing for imaging that shows the fragment, and for any report describing retrieval attempts.
- Check whether the model appears in an FDA recall or safety communication, and note the recall date against the implant date.
- Preserve the explanted fragment if it was retrieved — the physical device is evidence, and hospitals sometimes return it to the manufacturer.
- Note the date the fracture was discovered, since the limitations clock in most states runs from discovery rather than from implantation.
Frequently Asked Questions
Does a Class I FDA recall prove the manufacturer acted with malice?
No. A Class I designation describes the severity of the hazard, not the company's state of mind. It is useful evidence that the risk was real, but punitive damages still require clear and convincing proof of oppression, fraud or malice, and in corporate cases proof that an officer, director or managing agent knew.
Can I seek punitive damages against the hospital or the doctor who placed the catheter?
Those are separate claims with separate standards, and many states restrict punitive damages against healthcare providers more tightly than against manufacturers. A placement error is a malpractice theory; a device that broke from a material defect is a product theory.
If the fragment was removed successfully, is there still a case?
Potentially. Compensatory damages cover the retrieval procedure, its risks and its costs, along with any complications. The FDA has flagged procedural delay, vascular injury and hemorrhage among the harms a fracture can cause even short of embolism.